Literature DB >> 10983716

Progress in the clinical and molecular genetics of familial parkinsonism.

T Kitada1, S Asakawa, H Matsumine, N Hattori, H Shimura, S Minoshima, N Shimizu, Y Mizuno.   

Abstract

Parkinson's disease (PD) is a neurodegenerative disease with clinical features resulting from deficiency of dopamine in the nigrostriatal system. Most PD cases are sporadic and the primary cause of the disease is still unknown. Recently, familial PD and parkinsonism have received much attention because these forms of the disease might provide clues to the genetic risk factors involved in the pathogenesis of idiopathic PD. To date, two causative genes, alpha-synuclein and the parkin gene, have been identified. alpha-Synuclein is involved in the pathogenesis of an autosomal dominant form of PD and constitutes a major component of the Lewy body, which is a pathological hallmark of idiopathic PD. In addition, mutations in the parkin gene have been identified as the cause of autosomal recessive juvenile parkinsonism (AR-JP). AR-JP manifests itself as a highly selective degeneration of the substantia nigra and the locus coeruleus, but without Lewy body formation. In addition to these two genes, four chromosomal loci have been linked to other forms of familial PD. Furthermore, there are a number of other pedigrees of familial PD in which linkage to known genetic loci has been excluded. Molecular cloning of these disease genes and elucidation of the function of their gene products will greatly contribute to our understanding of the pathogenesis of idiopathic PD.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10983716     DOI: 10.1007/s100489900083

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  5 in total

Review 1.  Gene therapy in Parkinson's disease: rationale and current status.

Authors:  Li Rebekah Feng; Kathleen A Maguire-Zeiss
Journal:  CNS Drugs       Date:  2010-03       Impact factor: 5.749

2.  Synuclein activates microglia in a model of Parkinson's disease.

Authors:  Xiaomin Su; Kathleen A Maguire-Zeiss; Rita Giuliano; Landa Prifti; Karthik Venkatesh; Howard J Federoff
Journal:  Neurobiol Aging       Date:  2007-05-29       Impact factor: 4.673

3.  Nurr1 regulates Top IIβ and functions in axon genesis of mesencephalic dopaminergic neurons.

Authors:  Xin Heng; Gang Jin; Xin Zhang; Dehuang Yang; Mingzhe Zhu; Shijun Fu; Xuping Li; Weidong Le
Journal:  Mol Neurodegener       Date:  2012-02-02       Impact factor: 14.195

Review 4.  Neuromelanin and its interaction with iron as a potential risk factor for dopaminergic neurodegeneration underlying Parkinson's disease.

Authors:  Manfred Gerlach; Kay L Double; Dorit Ben-Shachar; Luigi Zecca; Moussa B H Youdim; Peter Riederer
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.978

5.  Significance of the parkin and PINK1 gene in Jordanian families with incidences of young-onset and juvenile parkinsonism.

Authors:  Ronny Myhre; Stina Steinkjer; Alice Stormyr; Gina L Nilsen; Hiba Abu Zayyad; Khalid Horany; Mohamad K Nusier; Helge Klungland
Journal:  BMC Neurol       Date:  2008-12-16       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.